Middle East, North Africa, Afghanistan & Pakistan vs Romania: Access to anti-retroviral drugs, male
Middle East, North Africa, Afghanistan & Pakistan
25.6%
in 2024
Romania
89.0%
in 2024
Middle East, North Africa, Afghanistan & Pakistan rank
17th
Romania rank
17th
Access to anti-retroviral drugs, male over time
- Middle East, North Africa, Afghanistan & Pakistan
- Romania
How they compare
Romania currently reports 89.0% against 25.6% in Middle East, North Africa, Afghanistan & Pakistan, a difference of 63.4%.
That makes Romania's figure about 3.5 times Middle East, North Africa, Afghanistan & Pakistan's.
Across all 25 years both countries report, Romania has been ahead every year.
Middle East, North Africa, Afghanistan & Pakistan ranks 17th and Romania ranks 17th of 19 groups.
Romania has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Middle East, North Africa, Afghanistan & Pakistan | Romania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.1% | 39.9% | 33.8% | Romania |
| 2010s | 12.2% | 59.8% | 47.6% | Romania |
| 2020s | 21.9% | 79.2% | 57.3% | Romania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Middle East, North Africa, Afghanistan & Pakistan or Romania?
- Romania, at 89.0% against 25.6% in Middle East, North Africa, Afghanistan & Pakistan as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Middle East, North Africa, Afghanistan & Pakistan and Romania?
- 63.4%, with Romania ahead.
- How many years of comparable data are there for Middle East, North Africa, Afghanistan & Pakistan and Romania?
- 25 years are reported by both, from 2000 to 2024.
- How do Middle East, North Africa, Afghanistan & Pakistan and Romania rank globally for access to anti-retroviral drugs, male?
- Middle East, North Africa, Afghanistan & Pakistan ranks 17th and Romania ranks 17th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.